medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2011, Número 5

<< Anterior Siguiente >>

Salud Mental 2011; 34 (5)


Manifestaciones clínicas y tratamiento del trastorno bipolar en niños y adolescentes, una actualización basada en la evidencia

Vargas–Soberanis A, Zavaleta-Ramírez P, Peña OF, Mayer VP, Gutiérrez-Soriano J, Palacios CL

Idioma: Español
Referencias bibliográficas: 58
Paginas: 409-414
Archivo PDF: 110.25 Kb.


RESUMEN

La fenomenología del trastorno bipolar pediátrico es distinta a la presentación clásica de este trastorno en adultos como lo indican las altas tasas de síntomas psicóticos, episodios de ciclaje rápido, alta duración de los episodios, así como la presencia de síntomas subsindromáticos por períodos largos. El pronóstico de los pacientes que inician la enfermedad durante la infancia y/o adolescencia es peor que para aquellos que la inician en la vida adulta. En la última década se ha incrementado la investigación farmacológica para este trastorno, los ensayos clínicos han mostrado que la respuesta de niños y adolescentes es distinta a la de los adultos, ofreciéndose mejores resultados con la combinación de psicofármacos. Las intervenciones psicosociales involucran a la psicoeducación y el entrenamiento en habilidades, pueden ser una alternativa de tratamiento para los niños y adolescentes con riesgo de desarrollar un trastorno bipolar.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community simple of older adolescents: prevalence, phenomenology, comorbidity and course. J Am Acad Child Adolesc Psychiatry 1995;34:454-463.

  2. National Institute of Mental Health. Research roundtable on prepubertad bipolar disorder. J Am Acad Child Adolesc Psychiatry 2001;40:871-878.

  3. Leibenluft E, Charney DS, Towbin KE, Bhangoo RK et al. Defining clinical phenotypes of juvenile mania. Am J Psychiatry 2003;160:430-437.

  4. Birmaher B, Axelson D, Goldstein B, Strober M et al. Four–year longitudinal course of children and adolescents with bipolar spectrum disorders: The course and outcome of bipolar youth (COBY) study. Am J Psychiatry 2009;166:795-804.

  5. Stringaris A, Baroni A, Haimm C, Brotman M et al. Pediatric bipolar disorder versus severe mood dysregulation: Risk for manic episodes on follow-up. J Am Acad Child Adolesc Psychiatry 2010;49:397-405.

  6. Geller B, Tiilman R, Bolhofner K, Zimerman B. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry 2008;65:1125-1133.

  7. Geller B, Zimerman B, Williams M, Bolhofner K et al. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 2001;40:450-455.

  8. Geller B, Zimerman B, Williams M, Delbello MP et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacology 2002;12:11-25.

  9. Mick E, Spencer T, Wozniak J, Biederman J. Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. Biol Psychiatry 2005;58:576-582.

  10. Jeffrey H, Birmaher B, Henrietta L, Strober M et al. Irritability without elation in a large bipolar youth sample: Frequency and clinical description. J Am Acad Child Adolesc Psychiatry 2009;48:730-739.

  11. Kowatch RA, Youngstrom EA, Danielyan A, Findling RL. Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord 2005;7:483–496.

  12. Task Force on DSM-IV. Mood disorders. En: Diagnostic and Statistical Manual of Mental Disorder. Cuarta edición. American Psychiatric Publishing; 2007; pp. 345-428.

  13. Geller B, Tillman R, Craney JL, Bolhofner K. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry 2004;61:459–467.

  14. Carlson GA, Kashani JH, Manic symptoms in a non-referred adolescent population. Affective Disorder 1988;15:219-226.

  15. Birmaher B, Axelson D, Strober M, Gill MK et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 2006;63:175-183.

  16. Geller B, Tillman R, Bolhofner K, Zimerman B. Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disorder 2010;12:164-711.

  17. Ketter TA. Strategies for the early recognition of bipolar disorder. J Clin Psychiatry 2011;72:e22.

  18. Tillman R, Geller B. Definitions of rapid, ultrarapid, and ultradian cycling and of episode duration in pediatric and adult bipolar disorders: A proposal to distinguish episodes from cycles. J Child Adolesc Psychopharmacol 2003; 13:267-271.

  19. Geller B, Zimerman B, Williams M, Bolhofner K et al. Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2000;10:157–164.

  20. Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP et al. Retrospective age at onset of bipolar disorder and outcome during two-year followup: results from the STEP-BD study. Bipolar Disorders 2009;11:391-400.

  21. Mick E, Biederman J, Pandina G, Faraone S. A Preliminary meta-analysis of the child behavior checklist in pediatric bipolar disorder. Biol Psychiatry 2003;53:1021-1027.

  22. Holtmann M, Bölte S, Goth K, Döpfner M et al. Prevalence of the child behavior checklist–pediatric bipolar disorder phenotype in a German general population sample. Bipolar Disorders 2007;9:895-900.

  23. Birmaher B, Axelson D, Goldstein B, Strober M et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry 2009;166:795-804.

  24. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R et al. Double- blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005;44:409-417.

  25. Pavuluri MN, Henry DB, Carbray JA, Taylor MW et al. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 2005;7:266-273.

  26. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007;164:1547-1556.

  27. Patel NC, DelBello MP, Bryan HS, Adler CM et al. Open-label lithium for the treatment od adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006;45:289-297.

  28. Biederman J, Mick E, Hammerness P, Harpold T et al. Open-label, 8- week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry 2005;58:589-594.

  29. Wagner KD, Redden L, Kowatch RA, Wilens TE et al. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 2009;48:519-532.

  30. Biederman J, Joshi G, Mick E, Doyle R et al. A prospective open-label trial of lamotrigine monotherapy in children and adolescents withbipolar disorder. CNS Neurosci Ther 2010;16:91-102.

  31. Joshi G, Wozniak J, Mick E, Doyle R et al. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. J Child Adolesc Psychopharmacol 2010;20:7-14.

  32. Haas M, Delbello MP, Pandina G, Pandina G et al. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2009;11687-11700.

  33. Duffy A, Milin R, Grof P. Maintenance treatment of adolescente bipolar disorder: open study of the effectiveness and tolerability of quetiapine. BMC Psychiatry 2009;9:4.

  34. Biederman J, Mick E, Spencer T, Dougherty M et al. A prospective openlabel treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord 2007;9:888-894.

  35. Findling RL, Nyilas M, Forbes RA, McQuade RD et al. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2009;70:1441-1451.

  36. Kowatch RA, Suppes T, Carmody TJ, Bucci JP et al. Effect Size of lithium, divalproex sodium, and carbamazepine in children and adolescents wit bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39: 713-720.

  37. Kafantaris V, Coletti DJ, Dicker R, Padula G et al. Lithium treatment of scute mania in sdolescents: A large open trial. J Am Acad Child Adolesc Psychiatry 2003;42:1038-1045.

  38. Findling RL, McNamara NK, Gracious BL, Youngstrom EA et al. Combination lithium and divalproaex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 2003;42:895-901.

  39. Findling RL, McNamara NK, Gracious BL, Youngstrom EA et al. Combination lithium and divalproaex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 2003;42:895-901.

  40. Pavuluri MN, Henry DB, Carbray JA, Naylor MW et al. Divalproex sodium for pediatric mixed mania: A 6-month Prospective trial. Bipolar Disord 2005;7:266-273.

  41. Wagner KD, Redden L, Kowatch RA; Wilens TE et al. Double blind, randomized, placebo-controlled trial of divalproex extended release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 2009;48:519-532.

  42. DelBello MP, Kowatch RA, Adler CM, Stanford KE et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006;45:305-313.

  43. Correl CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry 2007;46:687-700.

  44. Wozniak J, Mick E, Waxmonsky J, Kotarski M et al. A prospective openlabel treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2009; 19:539-545.

  45. Frazier JA, Biederman J, Tohen M, Feldman PD et al. A prospective openlabel treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11:239-250.

  46. Tramontina S, Zeni CP, Pheula GF, De Souza CK et al. Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial. CNS Spectr 2007;12:758-762.

  47. Biederman J, Mick E, Wozniak J, Aleardi M et al. An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2005;15:311-317.

  48. Biederman J, Mick E, Spencer T, Dougherty M et al. A prospective openlabel treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord 2007;9:888-894.

  49. Liu H, Potter M, Woodworth Y, Yorks DM et al. Pharmacologic treatments for pediatric bipolar disorder: A review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011;50:749-762.

  50. Strober M, Morrell W, Lampert C, Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry 1990;147:457-461.

  51. Patel N, Strakowski S. Open-label lithium for the treatment of adolescent with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006;45:289-297.

  52. Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM. Adoubleblind, randomized, placebo-controlled study of quetiapineas adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41:1216-1223.

  53. Miklowitz DJ, Chang KD, Taylor DO, George EL et al. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord 2011;13:67-75.

  54. Miklowitz DJ, Axelson DA, Birmaher B et al. Familyfocused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry 2008;65:1053–1061.

  55. Fristad MA, Verducci JS, Walters K, Young ME. Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders. Arch Gen Psychiatry 2009;66:1013–1021.

  56. West AE, Henry DB, Pavuluri MN. Maintenance model of integrated psychosocial treatment in pediatric bipolar disorder: A pilot feasibility study. J Am Acad Child Adolesc Psychiatry 2007;46:205–212.

  57. Nadkarni RB, Fristad MA. Clinical course of children with a depressive spectrum disorder and transient manic symptoms. Bipolar Disord 2010;12:494–503.

  58. Waxmonsky J, Pelham WE, Gnagy E et al. The efficacy and tolerability of methylphenidate and behavior modification in children with attention- deficit D hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol 2008;18:573–588.




2020     |     www.medigraphic.com